SUSAN E. KNIGHT - 05 Feb 2024 Form 4 Insider Report for SURMODICS INC (SRDX)

Role
Director
Signature
/s/ John D. Manders, on behalf of Susan E. Knight
Issuer symbol
SRDX
Transactions as of
05 Feb 2024
Net transactions value
-$15.85
Form type
4
Filing time
07 Feb 2024, 16:27:42 UTC
Previous filing
13 Feb 2023
Next filing
12 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SRDX Common Stock Options Exercise $94,171 +3,932 +12% $23.95 36,267 05 Feb 2024 Direct
transaction SRDX Common Stock Tax liability $94,187 -3,063 -8.4% $30.75 33,204 05 Feb 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SRDX Stock Option (right to buy) Options Exercise $0 -3,932 -100% $0.000000* 0 05 Feb 2024 Common Stock 3,932 $23.95 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The amount beneficially owned includes 15,342 restricted stock units (RSUs) that vest on service-based vesting dates that will be settled in shares of the issuer's common stock on a 1 for 1 basis when the reporting person's service as a director ends.
F2 Fully vested.